| Labatec Pharma SA - Lundeos, capsule molle |
| 67796 | | 02 | | Lundeos | | capsule molle | | A11CC05 | | Colecalciferol | | 17.02.2022 | | |
|
| Composition |
| cholecalciferolum 20000 U.I. corresp. cholecalciferolum 500 µg, triglycerida media, int-rac-alpha-tocopherylis acetas, gelatina, glycerolum, sorbitolum liquidum partim deshydricum corresp. sorbitolum max. 3.64 mg, aqua purificata, pro capsula. |
| Packungsbestandteile |
| Capsules molles | | | | | Principe actif | Concentr. |
|---|
| Cholecalciferol | 20000 UI correspond Cholecalciferol 500 µg |
| | BAG: Principe actif | Concentr. |
|---|
| Cholecalciferolum (Vitamin D3) | 20000 UI |
| | | | Agents auxilliaires |
|---|
| Aqua Purificata | | Gelatina | | Glycerol | | Int-Rac-Alpha-Tocopherylis Acetas | | Pro Capsula | | Sorbitolum Liquidum Partim Deshydricum | | Triglycerida Media |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 4 | 4.28 | 13.90 | B | LS | Oui | | 003 | 2 x 4 | DDP | DDP | B | | Oui |
|
